Cargando…
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
BACKGROUND: Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients due to accelerated atherosclerosis. Plasma osteoprotegerin (OPG) has evolved as a biomarker for CVD. We examined the relationship between plasma OPG levels and different CVD manifestations in type 2 diabetes. M...
Autores principales: | Poulsen, Mikael K, Nybo, Mads, Dahl, Jordi, Hosbond, Susanne, Poulsen, Tina S, Johansen, Allan, Høilund-Carlsen, Poul F, Beck-Nielsen, Henning, Rasmussen, Lars M, Henriksen, Jan E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163516/ https://www.ncbi.nlm.nih.gov/pubmed/21838881 http://dx.doi.org/10.1186/1475-2840-10-76 |
Ejemplares similares
-
Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients
por: Pedersen, Lise, et al.
Publicado: (2014) -
Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study
por: Poulsen, Mads Hvid, et al.
Publicado: (2019) -
A prospective study on dual time (18)F-FDG-PET/CT in high-risk prostate cancer patients
por: Mortensen, Mike Allan, et al.
Publicado: (2018) -
(18)F-Fluoromethylcholine-positron emission tomography/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancer
por: Mortensen, Mike Allan, et al.
Publicado: (2019) -
The good rays: let them shine!
por: Høilund-Carlsen, Poul F.
Publicado: (2018)